Kestra Medical Technologies(KMTS)
Focus: Kestra Medical Technologies is a publicly traded wearable medical device company focused on cardiovascular and metabolic disease monitoring and intervention. The company generated $28M in revenue in FY 2025 with a strong R&D commitment of 56% intensity.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
33-36 this month
Contracting — net -36 jobs in 30d
2 added, 38 removed. Active reduction in progress.
Should You Work at Kestra Medical Technologies?
AI assessmentA high-risk, high-reward IPO-stage play best suited for commercial professionals betting on wearable cardiovascular device adoption, not for those seeking R&D depth or financial stability.
Why Work Here
- Post-IPO growth stage with 69 active job openings, predominantly in commercial expansion (67 commercial roles), indicating aggressive market launch strategy
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$28M
Key Products
ASSURE™ Wearable Cardioverter Defibrillator
Growing
Growth
Lead commercial product targeting sudden cardiac death prevention via wearable technology; primary driver of $28M FY 2025 revenue.
Pipeline & Clinical Trials
Help build intelligence for Kestra Medical Technologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.